BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24012122)

  • 1. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.
    Ranjan N; Kumar S; Watkins D; Wang D; Appella DH; Arya DP
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5689-93. PubMed ID: 24012122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Click dimers to target HIV TAR RNA conformation.
    Kumar S; Kellish P; Robinson WE; Wang D; Appella DH; Arya DP
    Biochemistry; 2012 Mar; 51(11):2331-47. PubMed ID: 22339203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold.
    Kumar S; Ranjan N; Kellish P; Gong C; Watkins D; Arya DP
    Org Biomol Chem; 2016 Feb; 14(6):2052-6. PubMed ID: 26765486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of HIV TAR RNA by triazole linked neomycin dimers.
    Kumar S; Arya DP
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4788-92. PubMed ID: 21757341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure.
    Dassonneville L; Hamy F; Colson P; Houssier C; Bailly C
    Nucleic Acids Res; 1997 Nov; 25(22):4487-92. PubMed ID: 9358156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of B-DNA by neomycin--Hoechst 33258 conjugates.
    Willis B; Arya DP
    Biochemistry; 2006 Aug; 45(34):10217-32. PubMed ID: 16922497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing interaction of a fluorescent ligand with HIV TAR RNA.
    Qi L; Zhang J; He T; Huo Y; Zhang ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.
    Faber C; Sticht H; Schweimer K; Rösch P
    J Biol Chem; 2000 Jul; 275(27):20660-6. PubMed ID: 10747964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Evaluation of Neomycin-Imidazole Conjugates for RNA Cleavage.
    Martin C; Bonnet M; Patino N; Azoulay S; Di Giorgio A; Duca M
    Chempluschem; 2022 Nov; 87(11):e202200250. PubMed ID: 36148854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple recognition of B-DNA by a neomycin-Hoechst 33258-pyrene conjugate.
    Willis B; Arya DP
    Biochemistry; 2010 Jan; 49(3):452-69. PubMed ID: 20000367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    Lapidot A; Vijayabaskar V; Litovchick A; Yu J; James TL
    FEBS Lett; 2004 Nov; 577(3):415-21. PubMed ID: 15556620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
    Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
    Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.
    Zeiger M; Stark S; Kalden E; Ackermann B; Ferner J; Scheffer U; Shoja-Bazargani F; Erdel V; Schwalbe H; Göbel MW
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5576-5580. PubMed ID: 25466178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic characterization of TAR RNA-Tat peptide and neomycin interactions by acoustic wave biosensor.
    Tassew N; Thompson M
    Biophys Chem; 2003 Dec; 106(3):241-52. PubMed ID: 14556896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
    Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
    Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.